Ranbaxy Pharmaceuticals, Inc.

Cases where party is a Patent Asserter

Displaying 1 - 2 of 2
# Title Civil Action Venue Filing Date Asserter Categories Patent Asserter Alleged Infringer
1 Pfizer Inc et al v. Ranbaxy Laboratories Limited et al 1:08-cv-00164 D.Del.
  • 8 Product company
Ranbaxy Pharmaceuticals, Inc.
2 APOTEX, INC. v. CEPHALON, INC. et al 2:06-cv-02768 E.D.Pa.
  • 8 Product company
Ranbaxy Pharmaceuticals, Inc.

Cases where party is an Alleged Infringer

Displaying 1 - 38 of 38
# Title Civil Action Venue Filing Date Asserter Categories Patent Asserter Alleged Infringer
1 Pfizer Inc., et al v. Ranbaxy Laboratories, et al 1:03-cv-00209 D.Del.
  • 8 Product company
Pfizer Ireland Pharmaceuticals
2 Pfizer Inc., et al v. Ranbaxy Laboratories, et al 1:03-cv-00209 D.Del.
  • 8 Product company
Warner-Lambert Export, Ltd.
3 Pfizer Inc., et al v. Ranbaxy Laboratories, et al 1:03-cv-00209 D.Del.
  • 8 Product company
Warner-Lambert Company
4 Pfizer Inc., et al v. Ranbaxy Laboratories, et al 1:03-cv-00209 D.Del.
  • 8 Product company
Warner-Lambert Company LLC
5 Pfizer Inc., et al v. Ranbaxy Laboratories, et al 1:03-cv-00209 D.Del.
  • 8 Product company
Pfizer, Inc
6 Ranbaxy Lab Ltd, et al v. Abbott Laboratories 1:04-cv-08078 N.D.Ill.
  • 8 Product company
Abbott Laboratories
7 In Re: Rivastigmine Patent Litigation 1:05-md-01661 S.D.N.Y.
  • 8 Product company
  • 13 Corporate-inventor-started company
Novartis AG
8 In Re: Rivastigmine Patent Litigation 1:05-md-01661 S.D.N.Y.
  • 8 Product company
  • 13 Corporate-inventor-started company
Novartis International Pharmaceutical Ltd.
9 In Re: Rivastigmine Patent Litigation 1:05-md-01661 S.D.N.Y.
  • 8 Product company
  • 13 Corporate-inventor-started company
Novartis Pharmaceuticals Corporation
10 In Re: Rivastigmine Patent Litigation 1:05-md-01661 S.D.N.Y.
  • 8 Product company
  • 13 Corporate-inventor-started company
Proterra AG
11 In Re: Rivastigmine Patent Litigation 1:05-md-01661 S.D.N.Y.
  • 8 Product company
  • 13 Corporate-inventor-started company
Novartis Pharma AG
12 Lupin Atlantis Holdings SA v. Ranbaxy Laboratories Limited et al 1:10-cv-00659 D.Del.
  • 8 Product company
Lupin Atlantis Holdings S.A.
13 Purdue Pharma L.P. et al v. Ranbaxy Inc. et al 1:11-cv-07104 S.D.N.Y.
  • 8 Product company
Purdue Pharma L.P.
14 Purdue Pharma L.P. et al v. Ranbaxy Inc. et al 1:11-cv-07104 S.D.N.Y.
  • 8 Product company
The P.F. Laboratories, Inc.
15 Purdue Pharma L.P. et al v. Ranbaxy Inc. et al 1:11-cv-07104 S.D.N.Y.
  • 8 Product company
Rhodes Technologies
16 Teijin Limited et al v. Ranbaxy Pharmaceuticals Inc. et al 1:14-cv-00117 D.Del.
  • 8 Product company
Teijin Limited
17 Teijin Limited et al v. Ranbaxy Pharmaceuticals Inc. et al 1:14-cv-00117 D.Del.
  • 8 Product company
Teijin Pharma Limited
18 Teijin Limited et al v. Ranbaxy Pharmaceuticals Inc. et al 1:14-cv-00117 D.Del.
  • 8 Product company
Takeda Pharmaceuticals America Inc
19 SCHERING CORPORATION v. RANBAXY LABORATORIES, et al 2:01-cv-02990 D.N.J.
  • 8 Product company
Schering Corporation
20 AVENTIS PHARMACEUTICALS INC. et al v. BARR LABORATORIES, INC. 2:04-cv-01064 D.N.J.
  • 8 Product company
Aventis Pharmaceuticals, Inc.
21 AVENTIS PHARMACEUTICALS INC. et al v. BARR LABORATORIES, INC. 2:04-cv-01064 D.N.J.
  • 8 Product company
AMR TECHNOLOGY, INC.
22 AVENTIS PHARMACEUTICALS INC. et al v. IMPAX LABORATORIES, INC. 2:04-cv-01076 D.N.J.
  • 8 Product company
Aventis Pharmaceuticals, Inc.
23 AVENTIS PHARMACEUTICALS INC. et al v. IMPAX LABORATORIES, INC. 2:04-cv-01076 D.N.J.
  • 8 Product company
AMR TECHNOLOGY, INC.
24 PFIZER INC., et al v. RANBAXY LABORATORIES, et al 3:03-cv-00792 D.N.J.
  • 8 Product company
Warner-Lambert Company LLC
25 PFIZER INC., et al v. RANBAXY LABORATORIES, et al 3:03-cv-00792 D.N.J.
  • 8 Product company
Warner-Lambert Export, Ltd.
26 PFIZER INC., et al v. RANBAXY LABORATORIES, et al 3:03-cv-00792 D.N.J.
  • 8 Product company
Warner-Lambert Company
27 PFIZER INC., et al v. RANBAXY LABORATORIES, et al 3:03-cv-00792 D.N.J.
  • 8 Product company
Pfizer Ireland Pharmaceuticals
28 PFIZER INC., et al v. RANBAXY LABORATORIES, et al 3:03-cv-00792 D.N.J.
  • 8 Product company
Pfizer, Inc
29 TAKEDA CHEMICAL, et al v. RANBAXY LABORATORIES, et al 3:03-cv-05055 D.N.J.
  • 8 Product company
Takeda Pharmaceuticals North America Inc
30 TAKEDA CHEMICAL, et al v. RANBAXY LABORATORIES, et al 3:03-cv-05055 D.N.J.
  • 8 Product company
Takeda Chemical Industries, Ltd.
31 ASTELLAS PHARMA, INC. et al v. RANBAXY, INC. et al 3:05-cv-02563 D.N.J.
  • 8 Product company
Astellas Pharma US, Inc.
32 ASTELLAS PHARMA, INC. et al v. RANBAXY, INC. et al 3:05-cv-02563 D.N.J.
  • 8 Product company
Boehringer Ingelheim Pharmaceuticals, Inc.
33 ASTRAZENECA AB et al v. RANBAXY PHARMACEUTICALS, INC. et al 3:05-cv-05553 D.N.J.
  • 8 Product company
Aktiebolaget Hassle
34 ASTRAZENECA AB et al v. RANBAXY PHARMACEUTICALS, INC. et al 3:05-cv-05553 D.N.J.
  • 8 Product company
KBI Inc.
35 ASTRAZENECA AB et al v. RANBAXY PHARMACEUTICALS, INC. et al 3:05-cv-05553 D.N.J.
  • 8 Product company
Astrazeneca LP
36 ASTRAZENECA AB et al v. RANBAXY PHARMACEUTICALS, INC. et al 3:05-cv-05553 D.N.J.
  • 8 Product company
Astrazeneca LP
37 ASTRAZENECA AB et al v. RANBAXY PHARMACEUTICALS, INC. et al 3:05-cv-05553 D.N.J.
  • 8 Product company
Astrazeneca AB
38 ASTRAZENECA AB et al v. RANBAXY PHARMACEUTICALS, INC. et al 3:05-cv-05553 D.N.J.
  • 8 Product company
KBI-E Inc.